RxDoctor Payments Data

Anuj Basil, MD

Clinical Cardiac Electrophysiology · Philadelphia, PANPI 1811131386

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $45,525 of the $64,957 with a category attached, or 70.1%. 10 manufacturers reported payments, led by Impulse Dynamics (USA) Inc. at 42.0% of the total. Reporting peaked in 2024 at $18,988 and has fallen 74.2% since, to $4,897 in 2025.

$64,957in general payments, 2019–2025

Across 230 payments — averaging $282.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Impulse Dynamics (USA) Inc.$27K
  • Medtronic$25K
  • Abbott$8K
  • Boston Scientific$2K
  • Biosense Webster, Inc.$2K
  • Medical Device Business Services, Inc.$332
  • plus $130 from 4 others
$4,645in research payments, 2019–2025

Across 22 payments — averaging $211.11 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Biotronik Inc.$5K

What the payments were for

  • Consulting fees$2,1783%
  • Speaking & faculty fees$45,52570%
  • Travel & lodging$7,95412%
  • Food & beverage$9,29914%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$64,957 in reported general payments places this provider in the 80th percentile of 201 clinical cardiac electrophysiology providers in Pennsylvania.

See all clinical cardiac electrophysiology providers in Pennsylvania →

Medicare billing

Part B allowed, 2024
$94,700
Medicare patients
303
Services billed
932

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban43$51,170
XareltoRivaroxaban15$11,276
Amiodarone Hcl65$1,811
Metoprolol Succinate33$516

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Philadelphia

See the full list for Pennsylvania →

Where these figures come from

Is this you, or does something look wrong? →